Arsanis

Invivyd

Invivyd develops monoclonal antibody therapies to protect immunocompromised patients from serious viral infectious diseases, including COVID-19 and measles.

C10 PHARMA

This biopharmaceutical company develops novel antibiotics to treat life-threatening bacterial infections and combat antimicrobial resistance for patients with unmet medical needs.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Radiant Biotherapeutics

This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.

Abgentis

This company develops broad-spectrum antibacterial drugs for pharmaceutical firms to treat acute, chronic, and drug-resistant infections.

ArgenX

This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.

Omnix Medical

This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.

Paratek

This company develops and supplies antibiotics and specialty medicines for healthcare providers treating serious infectious diseases and osteoporosis.